Top 50 Chemical Manufacturing in Austria

The startup develops a patented process to convert raw lignin from biomass into small lignin particles, enhancing its natural properties for industrial applications. This technology provides a sustainable and biodegradable alternative to harmful synthetic ingredients, such as UV filters and emulsifiers, reducing reliance on fossil resources.

besparkbio develops viral vector-based medicines and provides tailored process development and CMC services for vaccines, immuno-oncology, and cell and gene therapies. Their expertise in optimizing production processes enhances efficiency, scalability, and product quality, addressing the challenges of transitioning from scientific breakthroughs to clinical development.

CompreVie develops human in vitro systems using microfluidic technology and tissue engineering to enable precise screening of substances for pharmaceutical, chemical, and cosmetic applications. Their smart skin biochip mimics mechanical tissue damage and topical product application, providing a reliable alternative to traditional animal testing methods.

NXAI develops high-performance, efficient, and scalable AI models specifically for industrial applications using its proprietary xLSTM technology. This architecture delivers superior accuracy and faster inference across diverse domains, including time series, robotics, and biosciences. The company partners with industries to implement these advanced AI solutions, enhancing process competitiveness and future-proofing operations.

Arkeon Bio utilizes ancient archaea to convert industrial CO2 and inorganic gases into climate-positive protein ingredients for food. This process addresses the dual challenges of carbon emissions and food sustainability by providing ethical, cruelty-free, and adaptable nutritional solutions.

Evologic Technologies specializes in the stabilization and industrial-scale production of living microbes, including sensitive bacteria and fungi, through advanced fermentation and formulation techniques. The company addresses the challenge of cultivating and maintaining the viability of hard-to-grow microorganisms for commercial applications in agriculture and biotechnology.

3YOURMIND provides an on-demand manufacturing software that enables companies to create digital inventories of qualified parts, optimizing production through data analysis and qualification management. This solution reduces operational costs by up to 30% and minimizes inventory levels by up to 75%, addressing the need for rapid spare parts production and efficient supply chain management.

Provides compliance automation software tailored for highly regulated industries, including manufacturing, aviation, and MedTech. The platform streamlines processes such as audit management, lifecycle tracking, and quality control, ensuring adherence to standards like ISO 9001, DO-178C, and MDR/IVDR while reducing manual effort and improving operational efficiency.

Innerspace provides a Virtual Reality simulator designed for training and assessing cleanroom personnel in the pharmaceutical industry, effectively reducing contamination risks through experiential learning. The platform enables operators to practice procedures in a risk-free environment, ensuring compliance with industry standards while minimizing production downtime and onboarding time.

The startup develops a high-resolution 3D printer specifically designed for bioprinting live cells using optimized biocompatible materials. This technology enables the production of sterile support structures for tissue regeneration, facilitating the creation of precise microcomponents essential for cell research.

This startup manufactures battery management systems utilizing lithium-ion technology to enhance battery lifespan, performance, and safety. Their systems optimize charging and discharging processes, accommodate various battery cell capacities, and minimize charging times, thereby reducing the carbon footprint for industries reliant on battery power.

The startup produces high-quality food ingredients by upcycling stone fruit pits, specifically from cherries, apricots, and plums, into sustainable raw materials for the dairy alternatives and confectionery industries. This process provides clients with environmentally friendly options while reducing food waste in the supply chain.

Planted utilizes proprietary structuring and fermentation technologies to create plant-based meat products that replicate the taste and texture of animal meat while using only clean ingredients. This approach addresses the unsustainable practices of the animal meat industry by offering a healthier, environmentally friendly alternative that is available in various forms across multiple European markets.

The startup develops a machine platform that integrates silicon chip technology with microfluidic processing for the large-scale manufacturing of personalized cell therapies. This technology enables real-time control and manipulation of cellular processes, providing cost-effective and safe treatments tailored for individual cancer patients.

CompoCloset supplies portable, waterless toilet solutions, specializing in composting and dry flush sealing systems. These units offer convenient waste management for off-grid living in applications like RVs, tiny homes, and boats. The company provides alternatives to chemical toilets that emphasize user experience and environmental consideration.

Everest commercializes a patent-pending alkalinity sensor that measures carbonate alkalinity in soil to quantify the atmospheric CO2 removal achieved through Enhanced Rock Weathering. By providing accurate and cost-effective monitoring, the technology enables scalable carbon removal solutions while supporting regenerative agriculture practices.

The startup develops antiviral therapies that inhibit viral replication by depriving viruses of essential nutrients, effectively starving them. This approach targets unmet medical needs in the treatment of various viral diseases, providing a novel method for patient care.

Heartbeat Bio develops advanced cardiac organoid screening platforms to accelerate cardiac drug discovery and development. The company utilizes multi-chamber heart organoids to model human heart development and disease states. This technology supports the identification of novel therapeutic targets for conditions like heart failure and inherited heart muscle disorders.

QUANTRO Therapeutics utilizes functional genetics and transcriptomics to create a novel cancer drug discovery pipeline that enhances the precision of cell-based compound screening. This approach addresses the need for more effective therapeutics in oncology by improving the identification of promising drug candidates.

HeiQ AeoniQ™ produces a climate-positive continuous cellulose filament yarn using sustainable raw materials like circulose® and agricultural waste, designed to replicate the properties of polyester and nylon. This yarn addresses the environmental impact of non-biodegradable synthetic fibers by offering a fully biodegradable and endlessly recyclable alternative that reduces CO2 emissions by five tons for every ton produced.

Visplore provides a plug-and-play visual analytics platform that enables users to integrate, explore, and prepare large time series data from various sources without coding. This tool significantly reduces data analysis time from days to minutes, allowing for rapid identification of insights and improved data quality for decision-making.

The startup develops customizable peptide-based biotherapeutics that utilize injectable peptide decoys to selectively remove drug-neutralizing antibodies and disease-causing autoantibodies from circulation. This technology addresses the challenge of enhancing the efficacy of biotherapeutic treatments in rare diseases with unmet clinical needs by providing pre-clinical and clinical developers with adaptable antibody-depleting compounds.

Proxygen is a biotechnology company developing molecular glue degraders that target and degrade disease-causing proteins through the cell's natural protein recycling machinery. This approach aims to provide new therapeutic options for cancer and other life-threatening diseases by effectively eliminating harmful proteins rather than merely inhibiting their function.

The startup manufactures biopharmaceuticals with automated systems and consumables designed for laboratory and GMP environments, implementing continuous processing to enhance operational efficiency. Their solutions enable clients to achieve higher productivity, reduced capital expenditures, and minimized facility space requirements.

Global Bus Ventures manufactures zero-emission buses and vehicles, utilizing proprietary vehicle management and telematics systems to enhance operational efficiency and performance. The company addresses the need for sustainable transport solutions by offering battery and hydrogen-powered vehicles with extended ranges, suitable for diverse operating environments.

Ahead is a biotech company that employs a proprietary platform for accelerated drug development through biomarker identification and predictive modeling. This technology reduces the time and costs associated with bringing new therapeutics to market by improving candidate selection and minimizing clinical trial failures.

The startup develops agricultural chemicals using fermentation and formulation technologies to cultivate previously un-culturable ingredients. This enables farmers to increase crop yields while minimizing fertilizer use, making sustainable agriculture more accessible and cost-effective.

Factorymaker offers an AI-powered platform that automates the generation and optimization of industrial building designs and site layouts. It integrates generative AI with simulations for process flow, architecture, and structural analysis, providing real-time economic and ecological feedback to enhance efficiency and sustainability.

New Path Bio produces animal‑free protein at industrial scale using engineered microbial fermentation of renewable feedstocks. Their closed‑loop bioreactor system delivers high‑quality, customizable protein blends with a low land and water footprint, suitable for food manufacturers, feed producers, and ingredient distributors.

Small New World Laboratories develops and manufactures human cell-derived biologics that enhance tissue regeneration while minimizing fibrotic scar formation. Their GMP-compliant processes support contract manufacturing and clinical testing, enabling researchers and commercial entities to advance therapeutic solutions effectively.

Carbon Cleanup provides a software component of its Recycling System that maps sustainable materials for injection molding and 3D printing. This technology enables manufacturers to source independent, eco-friendly materials, addressing the need for sustainable practices in production processes.

NAGENE specializes in the rapid synthesis of custom DNA sequences, utilizing a GMP-compliant, in-house process that ensures high-quality production within an average turnaround time of five days. This capability addresses the urgent need for reliable gene synthesis in pharmaceutical research and development, particularly for mRNA vaccines and cancer treatments.

Plasmics develops advanced multi-material 3D printing solutions featuring the INo Trident, the world's first commercially available induction heated hotend, which enhances print speed and quality. The startup addresses the lengthy production times of custom medical devices by enabling rapid, precise manufacturing of orthoses and prosthetics within hours instead of weeks.

Senseven has created a mobile inspection device that employs artificial intelligence for real-time data analysis, enhancing inspection accuracy and efficiency across various industries. This technology minimizes operational downtime and ensures compliance by providing immediate insights during inspections.

PulpStack provides an additive‑manufacturing system that converts cellulose into custom‑formulated filaments or powders for high‑performance, biodegradable 3D‑printed parts. Its proprietary extrusion/sintering process, integrated geometry‑optimization software, and post‑print curing deliver tensile strength, stiffness, and thermal stability comparable to petroleum‑based polymers, enabling manufacturers in automotive, aerospace, consumer goods, and medical devices to meet sustainability goals without sacrificing performance.

Quantics.io provides AI-driven supply chain planning solutions specifically designed for manufacturing companies, utilizing self-adapting forecasting and inventory management to enhance accuracy and responsiveness. Their technology addresses the challenges of demand variability and supply chain disruptions, enabling up to 90% faster planning and 70% more accurate forecasts.

The startup develops insect farming technology that utilizes organic by-products, such as fruits and vegetables, to cultivate insects, which are then processed into humus and high-protein animal feed. This approach reduces the ecological footprint of the food and feed industry while lowering disposal costs associated with organic waste.

The startup develops sustainable electrolytes for large-scale energy storage by converting waste materials from the paper industry into vanillin and electrochemically active components for redox flow batteries. This approach enables enterprises to minimize the environmental impact associated with traditional energy storage solutions.

The startup has developed a site-specific protein conjugation platform that enables the creation of targeted protein-drug conjugates for cancer treatment. This technology addresses the inefficiencies of traditional protein conjugation methods by allowing healthcare providers to produce receptor proteins with precise chemical modifications, enhancing therapeutic efficacy.

The startup has developed a dermal-targeted delivery system that utilizes a small molecule ligand to enhance the uptake of nanoparticles by Langerhans cells. This technology enables medical practitioners to effectively recognize foreign pathogens and induce systemic immune responses against cancer and infectious diseases.

Seisser Tech provides an AI-driven management platform that continuously ingests telemetry from heterogeneous enterprise systems and autonomously optimizes their operation using reinforcement‑learning and generative design. The platform translates high‑level business objectives entered via natural‑language into concrete configuration changes, executing them with safety constraints and audit trails. It delivers real‑time analytics and alerts, enabling large manufacturers, logistics networks, and cloud‑native platforms to reduce manual oversight and accelerate system improvements.

Carbony develops nature-based carbon removal projects across Europe, utilizing verified technologies to permanently eliminate CO2 emissions and support local climate initiatives. The platform provides businesses with tailored carbon removal roadmaps and feasibility studies, ensuring compliance with regulations while enhancing their sustainability strategies.

The startup manufactures metal powders for additive manufacturing, offering standard materials like stainless steel and aluminum, as well as customized options. Their laboratory services provide material analysis, enabling clients to optimize their additive manufacturing processes for improved efficiency and performance.

The startup develops a cartilage-on-a-chip technology that utilizes scalable organ-on-a-chip models to replace traditional animal testing in arthritis research. This approach enables healthcare providers to evaluate personalized treatment responses more efficiently and cost-effectively.

The startup operates a digital drug discovery platform that utilizes a proprietary computational analytics system and artificial intelligence to identify and validate candidate drugs through biomedical testing. This approach enables researchers to efficiently match clinical indications with drug effects, targeting complex and rare diseases that lack effective treatments.

Moldsonics manufactures ultrasonic sensors specifically designed for the plastics processing industry, enabling non-contact measurement of critical quality parameters such as flow fronts and solidification behavior. This technology reduces production waste by at least 10%, lowers manufacturing costs, and enhances overall process efficiency.

Enzyan Biocatalysis develops in vitro biocatalytic cascades that utilize compatible enzymes to convert renewable feedstocks into value-added chemical products, eliminating the need for living cells. This approach addresses inefficiencies in traditional chemical synthesis by streamlining reactions into a single vessel, reducing costs and environmental impact in chemical manufacturing.

The startup has developed a sensitive fluorescence platform that enhances the analytical sensitivity of fluorescence detection systems, enabling precise diagnostics in various applications. This technology allows users to achieve higher detection capabilities in environments with elevated electromagnetic fields, improving diagnostic accuracy and reliability.

Develops a proprietary cell-based phenotypic screening platform to identify small molecule inhibitors targeting protein-protein interactions (PPIs) involved in cancer. This approach addresses the challenge of developing therapeutics for difficult-to-treat cancers by enabling the discovery of novel treatments that disrupt critical molecular pathways.

This startup provides an analytical toolkit for characterizing lipid nanoparticles (LNPs) used in mRNA and gene therapies. Their capillary electrophoresis systems measure LNP particle size and RNA encapsulation efficiency, enabling real-time monitoring and optimization of therapeutic development processes.